相关实验视频

Updated: Jul 6, 2025

Primary Culture of Mouse Dopaminergic Neurons

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

SP1驱动的FOXM1上调诱导了帕金森病中的多巴胺基神经元损伤

Li Dong¹, Lianbo Gao²

¹Department of Neurology, The Fourth Affiliated Hospital of China Medical University, No. 4, Chongshan East Road, Huanggu District, Shenyang, 110032, Liaoning Province, People's Republic of China. ldong@cmu.edu.cn.

Molecular neurobiology

|January 10, 2024

概括

帕金森病涉及叉头盒M1 (FOXM1) 失调. SP1激活FOXM1,通过SNAI2/CXCL12通路驱动多巴氨基神经元损伤,这表明SP1沉默是一种神经保护策略.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
病理学病理学病理学

背景情况:

异常的叉头盒M1 (FOXM1) 表达与帕金森病 (PD) 病理学有关.
在PD中FOXM1的上游和下游调控机制仍然不清楚.
了解这些机制对于开发针对多巴氨基神经元损伤的向治疗至关重要.

研究的目的:

调查FOXM1在帕金森病中多巴胺基神经元损伤中的作用和调节机制.
在PD中识别FOXM1的上游调节器和下游目标.
评估针对SP1/FOXM1轴的治疗潜力.

主要方法:

生物信息学分析以确定差异性基因表达.
在罗诺诱导的帕金森病模型 (小鼠和细胞系) 中验证FOXM1表达.
用lentiviral向量媒介操纵SP1,FOXM1和CXCL12,以评估它们对多巴胺基神经元损伤的影响.

主要成果:

在PD模型中发现SP1,FOXM1,SNAI2和CXCL12的高度表达.
在实验室中,FOXM1沉默证明了神经保护作用,防止罗诺诱导的损伤.
SP1充当上游调节器,对FOXM1进行上游调节,这反过来又增加了SNAI2和CXCL12的表达,促进了多巴胺基神经元损伤.

结论:

在帕金森病中,SP1通过激活FOXM1/SNAI2/CXCL12信号轴来促进多巴氨基神经元损伤.
在多巴胺能神经元中,SP1沉默表现出神经保护作用.
通过SP1静音来非激活FOXM1/SNAI2/CXCL12轴为帕金森病提供了潜在的治疗策略.

关键词:

在CXCL12中,CXCL12是最重要的.多巴胺基神经元损伤的多巴胺基神经元损伤.在FOXM1中,我们可以看到FOXM1.帕金森病是帕金森氏症的一种疾病.这就是SNAI2的意思.SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1

更多相关视频

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.